Last Updated on October 11, 2024 by The Health Master
The World Health Organization (WHO) said that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe Covid-19, in a bid to increase access to the pricey drug.
The monoclonal antibody, used in anti-inflammatory drugs made by Swiss pharma giant Roche, has been shown to reduce the risk of death and also hospitalisation time in certain patients suffering from severe Covid.
WHO has, like the United States and the European Union, already recommended its use to treat severe Covid in hospital settings.
But it remains in short supply and is very expensive — a single dose reportedly goes for up to $600 in lower-income countries, WHO said, adding though that its prequalification should help make it more accessible.
The UN health agency said it had added three different compositions of the monoclonal antibody to its list of prequalified treatments for the pandemic disease, in a move aimed to spur more the production of more cheaper generic versions.
“The listings should pave the way for more companies coming forward to seek WHO prequalification, thereby increasing the number of quality-assured products and creating competition leading to potentially lower prices,” WHO said in a statement.
“The prequalification of these products will also facilitate low- and middle-income countries’ authorisation of them as Covid treatments,” it said.
WHO told AFP its prequalification process was primarily aimed at ensuring the quality, safety and efficacy of medical products procured to developing countries.
A prequalification provides assurances to countries that they are purchasing quality health products.
Prior to tocilizumab, the WHO has prequalified three different compositions for the steroid dexamethasone for treating Covid, as well as Gilead’s antiviral remdesivir, although that prequalification has since been suspended.
Drug alert: 27 out of 1227 samples declared as NSQ in January 2022
Gap in Price of Branded and Janaushadhi Medicine
DTAB recommendations to DCGI granting licenses under Clinical Trial
Govt issues draft notification on amendment on sale of Medical Devices
Four-side seal pouch machine introduced for Pharma Companies
Dr Reddy’s Laboratories launches generic Vasopressin injection USP
Biological E seeks extension from DCGI for its vaccine shelf life
USFDA gives nod to Lupin for Arformoterol Tartrate inhalation solution
Drug recall: Red Pill Capsules recalled due to this reason
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
